Evidence map›Paper›PMID 40886266›Full record

ReviewAdvances in experimental medicine and biology2025

An Overview of Circular RNAs.

Julia Mester-Tonczar, Ena Hasimbegovic

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Julia Mester-TonczarDepartment of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria. julia.mester-tonczar@meduniwien.ac.at.
Ena HasimbegovicDepartment of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circular RNAs (circRNAs) are a class of endogenous, covalently closed RNA molecules. Unlike linear RNAs, circRNAs are formed through noncanonical splicing, during which a downstream donor site is ligated with an upstream splice acceptor site, building a backsplice junction (BSJ), the distinguishing feature of circRNAs. The inherent feature of circRNAs is their lack of 5' cap structures and 3' poly(A) tails, which are typically found in linear RNAs. Due to their resistance to exonucleases, they exhibit increased stability compared to linear RNAs. In the past, circRNAs have been shown to be evolutionarily conserved and possess cell-type and tissue-specific expression patterns. The various important biological functions of circRNAs, including their roles as protein inhibitors (microRNA (miRNAs) sponges) and regulators of RNA-binding proteins (RBPs), have made them interesting biomolecules for the scientific community. However, due to the novelty of this research field, many obstacles are still present, arising from the lack of consensus on the precise methodological standards for reliable identification and nomenclature of newly identified circRNAs, inherent limitations of the applied methodologies, and the open questions regarding the mechanisms of action of this class of RNAs. This chapter will provide a brief summary of the discovery of circRNAs and the early related research. We will outline the importance of RNA sequencing technologies in circRNA research and highlight the more recent findings in this field, with a special focus on the different functions of circRNAs. Finally, we will discuss key challenges associated with circRNA research.

Indexed as

RNARNA, CircularAnimalsHumansMicroRNAsRNA-Binding ProteinsMicroRNAsRNARNA-Binding ProteinsRNA, CircularCircRNACircRNA functionsCircRNA overviewRNA-seq

Identifiers

PMID40886266

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.